comparemela.com

Covaxin Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covaxin Has Undergone All Necessary Trials: SC

Phase 3 efficacy trial of Covaxin revealed that the vaccine is 77.8 percent effective against Covid-19 infection.

Covaxin trial results for 2-18 age group pave way for inoculation of kids

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.